Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancer

BACKGROUND: Two promising therapeutic strategies in oncology are chimeric antigen receptor-T cell (CAR-T) therapies and antibody–drug conjugates (ADCs). To be effective and safe, these immunotherapies require surface antigens to be sufficiently expressed in tumors and less or not expressed in normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Schettini, F., Barbao, P., Brasó-Maristany, F., Galván, P., Martínez, D., Paré, L., De Placido, S., Prat, A., Guedan, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038941/
https://www.ncbi.nlm.nih.gov/pubmed/33838601
http://dx.doi.org/10.1016/j.esmoop.2021.100102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038941/
https://www.ncbi.nlm.nih.gov/pubmed/33838601
http://dx.doi.org/10.1016/j.esmoop.2021.100102

Ejemplares similares